关注
Yingwen Hu
Yingwen Hu
Novavax
在 novavax.com 的电子邮件经过验证
标题
引用次数
引用次数
年份
Selective redox-responsive drug release in tumor cells mediated by chitosan based glycolipid-like nanocarrier
Y Hu, Y Du, N Liu, X Liu, T Meng, B Cheng, J He, J You, H Yuan, F Hu
Journal of Controlled Release 206, 91-100, 2015
2012015
Redox-Responsive Polymer–Drug Conjugates Based on Doxorubicin and Chitosan Oligosaccharide-g-stearic Acid for Cancer Therapy
Y Su, Y Hu, Y Du, X Huang, J He, J You, H Yuan, F Hu
Molecular Pharmaceutics 12 (4), 1193-1202, 2015
1162015
Assessment of folate receptor alpha and beta expression in selection of lung and pancreatic cancer patients for receptor targeted therapies
J Shen, Y Hu, KS Putt, S Singhal, H Han, DW Visscher, LM Murphy, ...
Oncotarget 9 (4), 4485, 2018
782018
A54 peptide modified and redox-responsive glucolipid conjugate micelles for intracellular delivery of doxorubicin in hepatocarcinoma therapy
N Liu, Y Tan, Y Hu, T Meng, L Wen, J Liu, B Cheng, H Yuan, X Huang, ...
ACS applied materials & interfaces 8 (48), 33148-33156, 2016
552016
The utility of asymmetric flow field-flow fractionation for preclinical characterization of nanomedicines
Y Hu, RM Crist, JD Clogston
Analytical and Bioanalytical Chemistry, 2019
412019
Depletion of activated macrophages with a folate receptor-beta-specific antibody improves symptoms in mouse models of rheumatoid arthritis
Y Hu, B Wang, J Shen, SA Low, KS Putt, HWM Niessen, EL Matteson, ...
Arthritis research & therapy 21, 1-14, 2019
332019
Redox-responsive polymer inhibits macrophages uptake for effective intracellular gene delivery and enhanced cancer therapy
L Wen, Y Hu, T Meng, Y Tan, M Zhao, S Dai, H Yuan, F Hu
Colloids and Surfaces B: Biointerfaces 175, 392-402, 2019
212019
Effect of anionic PEGylated polypeptide on gene transfection mediated by glycolipid conjugate micelles
HX Yi, J Wu, YZ Du, YW Hu, H Yuan, J You, FQ Hu
Molecular pharmaceutics 12 (4), 1072-1083, 2015
182015
Application of lipid-based nanoparticles in cancer immunotherapy
Z Zhang, S Yao, Y Hu, X Zhao, RJ Lee
Frontiers in immunology 13, 967505, 2022
172022
Multi-cycle chemotherapy with the glycolipid-like polymeric micelles evade cancer stem cell enrichment in breast cancer therapy
T Meng, J Liu, L Wen, M Yuan, B Cheng, Y Hu, Y Zhu, X Liu, H Yuan, F Hu
Oncotarget 7 (45), 72978, 2016
142016
Sequential delivery of therapeutic agents using a rationally designed disulfide-linked glycolipid-like nanocarrier
Y Hu, N Liu, B Cheng, Y Tan, L Wen, H Yuan, F Hu
Oncotarget 7 (50), 83258, 2016
132016
Efficient capture of circulating tumor cells with low molecular weight folate receptor-specific ligands
Y Hu, D Chen, JV Napoleon, M Srinivasarao, S Singhal, CA Savran, ...
Scientific Reports 12 (1), 8555, 2022
102022
Antitumor Activity of Anti‐miR‐21 Delivered through Lipid Nanoparticles
Z Zhang, Y Huang, J Li, F Su, JCT Kuo, Y Hu, X Zhao, RJ Lee
Advanced Healthcare Materials 12 (6), 2202412, 2023
62023
Total drug quantification in prodrugs using an automated elemental analyzer
Y Hu, DM Stevens, S Man, RM Crist, JD Clogston
Drug Delivery and Translational Research 9, 1057-1066, 2019
32019
Quantitation of Active Pharmaceutical Ingredients in Polymeric Drug Products Using Elemental Analysis
J Xu, Y Hu, JD Clogston
Characterization of Nanoparticles Intended for Drug Delivery, 35-43, 2024
12024
Selective redox-responsive siRNA delivery mediated by chitosan based glycolipid-like nanocarrier
Y Hu, N Liu, Y Tan, F Hu
Nanomedicine: Nanotechnology, Biology and Medicine 2 (12), 549-550, 2016
12016
Optimized Liposomal Delivery of Bortezomib for Advancing Treatment of Multiple Myeloma
C Zhang, JCT Kuo, Y Huang, Y Hu, L Deng, BC Yung, X Zhao, Z Zhang, ...
Pharmaceutics 15 (12), 2674, 2023
2023
Asymmetric-Flow Field-Flow Fractionation
JD Clogston, Y Hu
National Cancer Institute’s Nanotechnology Characterization Laboratory Assay …, 2020
2020
Asymmetric-Flow Field-Flow Fractionation: Version 1.0
JD Clogston, Y Hu
National Cancer Institute’s Nanotechnology Characterization Laboratory Assay …, 2005
2005
Quantitation of APIs in Polymeric Prodrug Formulations: Version 1.0
JD Clogston, Y Hu
National Cancer Institute’s Nanotechnology Characterization Laboratory Assay …, 2005
2005
系统目前无法执行此操作,请稍后再试。
文章 1–20